Diffusion-weighted magnetic resonance imaging for predicting the response of rectal cancer to neoadjuvant concurrent chemoradiation

World Journal of Gastroenterology

Volumn 19, Issue 33, 2013, Pages 5520-5527

  Cai, Gang ^a,b   Xu, Ye ^a,b   Zhu, Ji ^a,b   Gu, Wei Lie ^a,b   Zhang, Shuai ^a,b   Ma, Xue Jun ^a,b   Cai, San Jun ^a,b   Zhang, Zhen ^a,b  

^a FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

Apparent diffusion coefficient; Diffusion weighted magnetic resonance imaging; Locally advanced rectal cancer; Neoadjuvant chemoradiation

Indexed keywords

CAPECITABINE; OXALIPLATIN;

ADJUVANT CHEMORADIOTHERAPY; ADULT; AGED; ARTICLE; CANCER STAGING; CLINICAL ARTICLE; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; ECHOGRAPHY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; PREDICTION; PROSPECTIVE STUDY; RECTUM CANCER; TREATMENT RESPONSE; TUMOR REGRESSION;

APPARENT DIFFUSION COEFFICIENT; DIFFUSION-WEIGHTED MAGNETIC RESONANCE IMAGING; LOCALLY ADVANCED RECTAL CANCER; NEOADJUVANT CHEMORADIATION;

ADENOCARCINOMA; ADULT; AGED; CHEMORADIOTHERAPY, ADJUVANT; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RECTAL NEOPLASMS; YOUNG ADULT;

EID: 84883522137     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v19.i33.5520     Document Type: Article

References (30)

1. Folkesson J, Birgisson H, Pahlman L, Cedermark B, Glimelius B, Gunnarsson U. Swedish Rectal Cancer Trial: long lasting benefits from radiotherapy on survival and local recurrence rate. J Clin Oncol 2005; 23: 5644-5650 [PMID: 16110023 DOI: 10.1200/JCO.2005.08.144]
2. Sauer R, Becker H, Hohenberger W, Rödel C, Wittekind C, Fietkau R, Martus P, Tschmelitsch J, Hager E, Hess CF, Karstens JH, Liersch T, Schmidberger H, Raab R. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004; 351: 1731-1740 [PMID: 15496622 DOI: 10.1056/NEJMoa040694]
3. Popek S, Tsikitis VL. Neoadjuvant vs adjuvant pelvic radiotherapy for locally advanced rectal cancer: Which is superior? World J Gastroenterol 2011; 17: 848-854 [PMID: 21412494 DOI: 10.3748/wjg.v17.i7.848]
4. Onaitis MW, Noone RB, Hartwig M, Hurwitz H, Morse M, Jowell P, McGrath K, Lee C, Anscher MS, Clary B, Mantyh C, Pappas TN, Ludwig K, Seigler HF, Tyler DS. Neoadjuvant chemoradiation for rectal cancer: analysis of clinical outcomes from a 13-year institutional experience. Ann Surg 2001; 233: 778-785 [PMID: 11371736 DOI: 10.1097/00000658-200106000-00007]
5. Habr-Gama A, Perez RO, Nadalin W, Nahas SC, Ribeiro U, Silva E Sousa AH, Campos FG, Kiss DR, Gama-Rodrigues J. Long-term results of preoperative chemoradiation for distal rectal cancer correlation between final stage and survival. J Gastrointest Surg 2005; 9: 90-99; discussion 99-101 [PMID: 15623449 DOI: 10.1016/j.gassur.2004.10.010]
6. Habr-Gama A, Perez RO, Nadalin W, Sabbaga J, Ribeiro U, Silva e Sousa AH, Campos FG, Kiss DR, Gama-Rodrigues J. Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results. Ann Surg 2004; 240: 711-717; discussion 717-718 [PMID: 15383798]
7. Chenevert TL, Stegman LD, Taylor JM, Robertson PL, Greenberg HS, Rehemtulla A, Ross BD. Diffusion magnetic resonance imaging: an early surrogate marker of therapeutic efficacy in brain tumors. J Natl Cancer Inst 2000; 92: 2029-2036 [PMID: 11121466]
8. Hamstra DA, Rehemtulla A, Ross BD. Diffusion magnetic resonance imaging: a biomarker for treatment response in oncology. J Clin Oncol 2007; 25: 4104-4109 [PMID: 17827460 DOI: 10.1200/JCO.2007.11.9610]
9. deSouza NM, Riches SF, Vanas NJ, Morgan VA, Ashley SA, Fisher C, Payne GS, Parker C. Diffusion-weighted magnetic resonance imaging: a potential non-invasive marker of tumour aggressiveness in localized prostate cancer. Clin Radiol 2008; 63: 774-782 [PMID: 18555035 DOI: 10.1016/ j.crad.2008.02.001]
10. Dzik-Jurasz A, Domenig C, George M, Wolber J, Padhani A, Brown G, Doran S. Diffusion MRI for prediction of response of rectal cancer to chemoradiation. Lancet 2002; 360: 307-308 [PMID: 12147376 DOI: 10.1016/S0140-6736(02)09520-X]
11. DeVries AF, Kremser C, Hein PA, Griebel J, Krezcy A, Ofner D, Pfeiffer KP, Lukas P, Judmaier W. Tumor microcirculation and diffusion predict therapy outcome for primary rectal carcinoma. Int J Radiat Oncol Biol Phys 2003; 56: 958-965 [PMID: 12829130 DOI: 10.1016/S0360-3016(03)00208-6]
12. Kim SH, Lee JM, Hong SH, Kim GH, Lee JY, Han JK, Choi BI. Locally advanced rectal cancer: added value of diffusionweighted MR imaging in the evaluation of tumor response to neoadjuvant chemo-and radiation therapy. Radiology 2009; 253: 116-125 [PMID: 19789256 DOI: 10.1148/radiol. 2532090027]
13. Greene FL. Current TNM staging of colorectal cancer. Lancet Oncol 2007; 8: 572-573 [PMID: 17613421 DOI: 10.1016/ S1470-2045(07)70185-7]
14. Dworak O, Keilholz L, Hoffmann A. Pathological features of rectal cancer after preoperative radiochemotherapy. Int J Colorectal Dis 1997; 12: 19-23 [PMID: 9112145 DOI: 10.1007/ s003840050072]
15. Herneth AM, Guccione S, Bednarski M. Apparent diffusion coefficient: a quantitative parameter for in vivo tumor characterization. Eur J Radiol 2003; 45: 208-213 [PMID: 12595105 DOI: 10.1016/S0720-048X(02)00310-8]
16. Mardor Y, Pfeffer R, Spiegelmann R, Roth Y, Maier SE, Nissim O, Berger R, Glicksman A, Baram J, Orenstein A, Cohen JS, Tichler T. Early detection of response to radiation therapy in patients with brain malignancies using conventional and high b-value diffusion-weighted magnetic resonance imaging. J Clin Oncol 2003; 21: 1094-1100 [PMID: 12637476 DOI: 10.1200/JCO.2003.05.069]
17. Song I, Kim CK, Park BK, Park W. Assessment of response to radiotherapy for prostate cancer: value of diffusionweighted MRI at 3 T. AJR Am J Roentgenol 2010; 194: W477-W482 [PMID: 20489065 DOI: 10.2214/AJR.09.3557]
18. Hein PA, Kremser C, Judmaier W, Griebel J, Pfeiffer KP, Kreczy A, Hug EB, Lukas P, DeVries AF. Diffusion-weighted magnetic resonance imaging for monitoring diffusion changes in rectal carcinoma during combined, preoperative chemoradiation: preliminary results of a prospective study. Eur J Radiol 2003; 45: 214-222 [PMID: 12595106 DOI: 10.1016/S0720-048X(02)00231-0]
19. Rödel C, Martus P, Papadoupolos T, Füzesi L, Klimpfinger M, Fietkau R, Liersch T, Hohenberger W, Raab R, Sauer R, Wittekind C. Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer. J Clin Oncol 2005; 23: 8688-8696 [PMID: 16246976 DOI: 10.1200/ JCO.2005.02.1329]
20. Chapet O, Romestaing P, Mornex F, Souquet JC, Favrel V, Ardiet JM, d'Hombres A, Gerard JP. Preoperative radiotherapy for rectal adenocarcinoma: Which are strong prognostic factors? Int J Radiat Oncol Biol Phys 2005; 61: 1371-1377 [PMID: 15817339 DOI: 10.1016/j.ijrobp.2004.08.022]
21. Koh DM, Scurr E, Collins D, Kanber B, Norman A, Leach MO, Husband JE. Predicting response of colorectal hepatic metastasis: value of pretreatment apparent diffusion coefficients. AJR Am J Roentgenol 2007; 188: 1001-1008 [PMID: 17377036 DOI: 10.2214/AJR.06.0601]
22. Cui Y, Zhang XP, Sun YS, Tang L, Shen L. Apparent diffusion coefficient: potential imaging biomarker for prediction and early detection of response to chemotherapy in hepatic metastases. Radiology 2008; 248: 894-900 [PMID: 18710982 DOI: 10.1148/radiol.2483071407]
23. Mardor Y, Roth Y, Ochershvilli A, Spiegelmann R, Tichler T, Daniels D, Maier SE, Nissim O, Ram Z, Baram J, Orenstein A, Pfeffer R. Pretreatment prediction of brain tumors' response to radiation therapy using high b-value diffusionweighted MRI. Neoplasia 2004; 6: 136-142 [PMID: 15140402 DOI: 10.1593/neo.03349]
24. Lambrecht M, Vandecaveye V, De Keyzer F, Roels S, Penninckx F, Van Cutsem E, Filip C, Haustermans K. Value of diffusion-weighted magnetic resonance imaging for prediction and early assessment of response to neoadjuvant radiochemotherapy in rectal cancer: preliminary results. Int J Radiat Oncol Biol Phys 2012; 82: 863-870 [PMID: 21398048 DOI: 10.1016/j.ijrobp.2010.12.063]
25. Sun YS, Zhang XP, Tang L, Ji JF, Gu J, Cai Y, Zhang XY. Locally advanced rectal carcinoma treated with preoperative chemotherapy and radiation therapy: preliminary analysis of diffusion-weighted MR imaging for early detection of tumor histopathologic downstaging. Radiology 2010; 254: 170-178 [PMID: 20019139 DOI: 10.1148/radiol.2541082230]
26. Uhl M, Saueressig U, van Buiren M, Kontny U, Niemeyer C, Köhler G, Ilyasov K, Langer M. Osteosarcoma: preliminary results of in vivo assessment of tumor necrosis after chemotherapy with diffusion-and perfusion-weighted magnetic resonance imaging. Invest Radiol 2006; 41: 618-623 [PMID: 16829744 DOI: 10.1097/01.rli.0000225398.17315.68]
27. Harry VN, Semple SI, Gilbert FJ, Parkin DE. Diffusionweighted magnetic resonance imaging in the early detection of response to chemoradiation in cervical cancer. Gynecol Oncol 2008; 111: 213-220 [PMID: 18774597 DOI: 10.1016/ j.ygyno.2008.07.048]
28. Kim SH, Lee JY, Lee JM, Han JK, Choi BI. Apparent diffusion coefficient for evaluating tumour response to neoadjuvant chemoradiation therapy for locally advanced rectal cancer. Eur Radiol 2011; 21: 987-995 [PMID: 20978768 DOI: 10.1007/s00330-010-1989-y]
29. Kim YC, Lim JS, Keum KC, Kim KA, Myoung S, Shin SJ, Kim MJ, Kim NK, Suh J, Kim KW. Comparison of diffusionweighted MRI and MR volumetry in the evaluation of early treatment outcomes after preoperative chemoradiotherapy for locally advanced rectal cancer. J Magn Reson Imaging 2011; 34: 570-576 [PMID: 21751285 DOI: 10.1002/jmri.22696]
30. Ross BD, Moffat BA, Lawrence TS, Mukherji SK, Gebarski SS, Quint DJ, Johnson TD, Junck L, Robertson PL, Muraszko KM, Dong Q, Meyer CR, Bland PH, McConville P, Geng H, Rehemtulla A, Chenevert TL. Evaluation of cancer therapy using diffusion magnetic resonance imaging. Mol Cancer Ther 2003; 2: 581-587 [PMID: 12813138]